Requirement of the Shigella flexneri virulence plasmid in the ability to induce trafficking of neutrophils across polarized monolayers of the intestinal epithelium.
about
Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma proteinSerratia marcescens is injurious to intestinal epithelial cells.Shigella flexneri effectors OspE1 and OspE2 mediate induced adherence to the colonic epithelium following bile salts exposure.In vitro coculture assay to assess pathogen induced neutrophil trans-epithelial migration.Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway.The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies.Orchestration of neutrophil movement by intestinal epithelial cells in response to Salmonella typhimurium can be uncoupled from bacterial internalization.Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration.Shigella flexneri Interactions with the Basolateral Membrane Domain of Polarized Model Intestinal Epithelium: Role of Lipopolysaccharide in Cell Invasion and in Activation of the Mitogen-Activated Protein Kinase ERKThe human gut mobile metagenome: a metazoan perspective.OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulenceSaccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.Evolutionary, ecological and biotechnological perspectives on plasmids resident in the human gut mobile metagenomeEscherichia albertii, a novel human enteropathogen, colonizes rat enterocytes and translocates to extra-intestinal sitesA new understanding of enteroaggregative Escherichia coli as an inflammatory pathogen.The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.Distinct isoforms of phospholipase A2 mediate the ability of Salmonella enterica serotype typhimurium and Shigella flexneri to induce the transepithelial migration of neutrophils.Cytotoxic and Inflammatory Responses Induced by Outer Membrane Vesicle-Associated Biologically Active Proteases from Vibrio cholerae.Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell linesSpa15 of Shigella flexneri is secreted through the type III secretion system and prevents staurosporine-induced apoptosis.The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1.Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decay-accelerating factor (CD55), the receptor for Afa/Dr aThe Salmonella enterica serotype Typhi Vi capsular antigen is expressed after the bacterium enters the ileal mucosa.Shigella depends on SepA to destabilize the intestinal epithelial integrity via cofilin activation.Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures.
P2860
Q24315859-CCB49731-52AC-4607-B924-918D85A3CC12Q30301269-E9953631-CE90-49E6-BCEF-ED29763DB41DQ30418560-371B7D26-5C9F-49BB-A6E8-E11DEA3AA73EQ33778173-371567DC-7773-4350-8250-8A628B1786F4Q33870871-5CE2CCF3-27AF-4575-9F6D-D32A9A090E42Q33955468-C96D06B6-11ED-43C7-B22E-74ABDBB246CFQ34000197-A58F056B-14F7-4F42-B337-C6BC42FBDDE5Q34009274-2C182676-C139-4F7B-AE63-135F041A1F8FQ34120536-7C96D34A-F016-4E1B-A4B7-9E40F6ED7DD5Q34664136-C1635A4B-FEE8-4123-B538-AB158DE6ECD7Q35073836-F4DBD938-19DB-4C46-B575-E6B37F52F48FQ35540167-476489CA-7D90-40C2-B8FE-139D54603398Q35896703-288AB074-A475-452C-A5A4-2DBE87262606Q36274182-7A16E3D3-1FCA-41AD-8C65-D4A30C227CE6Q36394728-31045550-3080-4348-A213-D442C2B3D643Q36422115-61944F62-54E6-4C72-BA70-8BA251FE6B78Q36422508-8468561A-AD80-4474-93EF-CD505DE0EA02Q36804209-FF770811-32B9-4059-B075-A888C0A68438Q36888443-1297EBE4-5C8E-477B-81D7-E0E2023C94DAQ37264192-626911A6-3DB1-434A-B96F-B2CD21880C2AQ37451172-66F4AE21-7CDC-4F02-8DD2-AB952F3715BDQ39362868-1CCD6883-7EDA-4509-A94A-5A40B4D1AAAAQ39741717-4FD5CC91-1909-49DF-9076-C1822052EB83Q39777050-B2B2A211-E78E-47CF-BD7C-F5FAB4202EA2Q40178843-25A5413C-AA5A-49D7-9401-5824E0966943Q42018332-6C8FD55E-2982-418E-B07F-0C19BC0939F3
P2860
Requirement of the Shigella flexneri virulence plasmid in the ability to induce trafficking of neutrophils across polarized monolayers of the intestinal epithelium.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Requirement of the Shigella fl ...... of the intestinal epithelium.
@en
Requirement of the Shigella fl ...... of the intestinal epithelium.
@nl
type
label
Requirement of the Shigella fl ...... of the intestinal epithelium.
@en
Requirement of the Shigella fl ...... of the intestinal epithelium.
@nl
prefLabel
Requirement of the Shigella fl ...... of the intestinal epithelium.
@en
Requirement of the Shigella fl ...... of the intestinal epithelium.
@nl
P2093
P2860
P1476
Requirement of the Shigella fl ...... of the intestinal epithelium.
@en
P2093
A T Maurelli
B A McCormick
P2860
P304
P407
P577
1998-09-01T00:00:00Z